Do you see the handwriting on the wall with SNY working hard to get the rollout started but at the same time buy or accumulating low cost shares of MannKind on the open market. Since the August 11th announcement there has been a steady daily accumulation of shares. This accumulation either by SNY or institutional buyers is evident of the belief that the product will be a successful addition to the Sanofi diabetes product offering. What time frame do you think a buyout from Sanofi will be announced?
Before product launch?
12 or more months after launch?
Sanofi accumulation would be a smart buy in move before having to disclose in future quarterly announcements. At some point they have to disclose their buying of shares it that is truly happening.
Before product launch?
12 or more months after launch?
Sanofi accumulation would be a smart buy in move before having to disclose in future quarterly announcements. At some point they have to disclose their buying of shares it that is truly happening.
Sanofi to buy MannKind
Aucun commentaire:
Enregistrer un commentaire